HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ancsin, J. B. Articles by Kisilevsky, R. Search for Related Content PubMed PubMed Citation Articles by Ancsin, J. B. Articles by Kisilevsky, R. Social Bookmarking                      What's this?

J Biol Chem, Vol. 274, Issue 11, 7172-7181, March 12, 1999

The Heparin/Heparan Sulfate-binding Site on Apo-serum Amyloid A
IMPLICATIONS FOR THE THERAPEUTIC INTERVENTION OF AMYLOIDOSIS

From the Department of Pathology, Queen's University and the Syl and Molly Apps Research Center, Kingston General Hospital, Kingston, Ontario K7L 3N6, Canada

Serum amyloid A isoforms, apoSAA1 and apoSAA2, are apolipoproteins of unknown function that become major components of high density lipoprotein (HDL) during the acute phase of an inflammatory response. ApoSAA is also the precursor of inflammation-associated amyloid, and there is strong evidence that the formation of inflammation-associated and other types of amyloid is promoted by heparan sulfate (HS). Data presented herein demonstrate that both mouse and human apoSAA contain binding sites that are specific for heparin and HS, with no binding for the other major glycosaminoglycans detected. Cyanogen bromide-generated peptides of mouse apoSAA1 and apoSAA2 were screened for heparin binding activity. Two peptides, an apoSAA1-derived 80-mer (residues 24-103) and a smaller carboxyl-terminal 27-mer peptide of apoSAA2 (residues 77-103), were retained by a heparin column. A synthetic peptide corresponding to the CNBr-generated 27-mer also bound heparin, and by substituting or deleting one or more of its six basic residues (Arg-83, His-84, Arg-86, Lys-89, Arg-95, and Lys-102), their relative importance for heparin and HS binding was determined. The Lys-102 residue appeared to be required only for HS binding. The residues Arg-86, Lys-89, Arg-95, and Lys-102 are phylogenetically conserved suggesting that the heparin/HS binding activity may be an important aspect of the function of apoSAA. HS linked by its carboxyl groups to an Affi-Gel column or treated with carbodiimide to block its carboxyl groups lost the ability to bind apoSAA. HDL-apoSAA did not bind to heparin; however, it did bind to HS, an interaction to which apoA-I contributed. Results from binding experiments with Congo Red-Sepharose 4B columns support the conclusions of a recent structural study which found that heparin binding domains have a common spatial distance of about 20 Å between their two outer basic residues. Our present work provides direct evidence that apoSAA can associate with HS (and heparin) and that the occupation of its binding site by HS, and HS analogs, likely caused the previously reported increase in amyloidogenic conformation (-sheet) of apoSAA2 (McCubbin, W. D., Kay, C. M., Narindrasorasak, S., and Kisilevsky, R. (1988) Biochem. J. 256, 775-783) and their amyloid-suppressing effects in vivo (Kisilevsky, R., Lemieux, L. J., Fraser, P. E., Kong, X., Hultin, P. G., and Szarek, W. A. (1995) Nat. Med. 1, 143-147), respectively.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				R. Bravo, M. Arimon, J. J. Valle-Delgado, R. Garcia, N. Durany, S. Castel, M. Cruz, S. Ventura, and X. Fernandez-Busquets Sulfated Polysaccharides Promote the Assembly of Amyloid {beta}1-42 Peptide into Stable Fibrils of Reduced Cytotoxicity J. Biol. Chem., November 21, 2008; 283(47): 32471 - 32483. [Abstract] [Full Text] [PDF]

				C. Shah, R. Hari-Dass, and J. G. Raynes Serum amyloid A is an innate immune opsonin for Gram-negative bacteria Blood, September 1, 2006; 108(5): 1751 - 1757. [Abstract] [Full Text] [PDF]

				O. Gutfeld, D. Prus, Z. Ackerman, S. Dishon, R. P. Linke, M. Levin, and S. Urieli-Shoval Expression of Serum Amyloid A, in Normal, Dysplastic, and Neoplastic Human Colonic Mucosa: Implication for a Role in Colonic Tumorigenesis J. Histochem. Cytochem., January 1, 2006; 54(1): 63 - 73. [Abstract] [Full Text] [PDF]

				S. P. Tam, J. B. Ancsin, R. Tan, and R. Kisilevsky Peptides derived from serum amyloid A prevent, and reverse, aortic lipid lesions in apoE-/- mice J. Lipid Res., October 1, 2005; 46(10): 2091 - 2101. [Abstract] [Full Text] [PDF]

				R. Hari-Dass, C. Shah, D. J. Meyer, and J. G. Raynes Serum Amyloid A Protein Binds to Outer Membrane Protein A of Gram-negative Bacteria J. Biol. Chem., May 13, 2005; 280(19): 18562 - 18567. [Abstract] [Full Text] [PDF]

				K. D. O'Brien, T. O. McDonald, V. Kunjathoor, K. Eng, E. A. Knopp, K. Lewis, R. Lopez, E. A. Kirk, A. Chait, T. N. Wight, et al. Serum Amyloid A and Lipoprotein Retention in Murine Models of Atherosclerosis Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 785 - 790. [Abstract] [Full Text] [PDF]

				A. Chait, C. Y. Han, J. F. Oram, and J. W. Heinecke Thematic review series: The Immune System and Atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? J. Lipid Res., March 1, 2005; 46(3): 389 - 403. [Abstract] [Full Text] [PDF]

				V. Trinkaus-Randall, M. T. Walsh, S. Steeves, G. Monis, L. H. Connors, and M. Skinner Cellular Response of Cardiac Fibroblasts to Amyloidogenic Light Chains Am. J. Pathol., January 1, 2005; 166(1): 197 - 208. [Abstract] [Full Text] [PDF]

				K. E. Lewis, E. A. Kirk, T. O. McDonald, S. Wang, T. N. Wight, K. D. O'Brien, and A. Chait Increase in Serum Amyloid A Evoked by Dietary Cholesterol Is Associated With Increased Atherosclerosis in Mice Circulation, August 3, 2004; 110(5): 540 - 545. [Abstract] [Full Text] [PDF]

				R. Kisilevsky, W. A. Szarek, J. B. Ancsin, E. Elimova, S. Marone, S. Bhat, and A. Berkin Inhibition of Amyloid A Amyloidogenesis in Vivo and in Tissue Culture by 4-Deoxy Analogues of Peracetylated 2-Acetamido-2-Deoxy-{alpha}- and {beta}-D-Glucose: Implications for the Treatment of Various Amyloidoses Am. J. Pathol., June 1, 2004; 164(6): 2127 - 2137. [Abstract] [Full Text] [PDF]

				S. Yamamoto, I. Yamaguchi, K. Hasegawa, S. Tsutsumi, Y. Goto, F. Gejyo, and H. Naiki Glycosaminoglycans Enhance the Trifluoroethanol-Induced Extension of {beta}2-Microglobulin-Related Amyloid Fibrils at a Neutral pH J. Am. Soc. Nephrol., January 1, 2004; 15(1): 126 - 133. [Abstract] [Full Text] [PDF]

				R. Kisilevsky and S. P. Tam Macrophage cholesterol efflux and the active domains of serum amyloid A 2.1 J. Lipid Res., December 1, 2003; 44(12): 2257 - 2269. [Abstract] [Full Text] [PDF]

				L. Wang, H. A. Lashuel, T. Walz, and W. Colon Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel PNAS, December 10, 2002; 99(25): 15947 - 15952. [Abstract] [Full Text] [PDF]

				S. P. Tam, A. Flexman, J. Hulme, and R. Kisilevsky Promoting export of macrophage cholesterol: the physiological role of a major acute-phase protein, serum amyloid A 2.1 J. Lipid Res., September 1, 2002; 43(9): 1410 - 1420. [Abstract] [Full Text] [PDF]

				R. Kisilevsky, I. Crandall, W. A. Szarek, S. Bhat, C. Tan, L. Boudreau, and K. C. Kain Short-Chain Aliphatic Polysulfonates Inhibit the Entry of Plasmodium into Red Blood Cells Antimicrob. Agents Chemother., August 1, 2002; 46(8): 2619 - 2626. [Abstract] [Full Text] [PDF]

				S. Urieli-Shoval, G. Shubinsky, R. P. Linke, M. Fridkin, I. Tabi, and Y. Matzner Adhesion of human platelets to serum amyloid A Blood, February 15, 2002; 99(4): 1224 - 1229. [Abstract] [Full Text] [PDF]

				K. Park and C. B. Verchere Identification of a Heparin Binding Domain in the N-terminal Cleavage Site of Pro-islet Amyloid Polypeptide. IMPLICATIONS FOR ISLET AMYLOID FORMATION J. Biol. Chem., May 11, 2001; 276(20): 16611 - 16616. [Abstract] [Full Text] [PDF]